A team from Cozen O’Connor’s lobbying arm has signed up to advocate for Curaleaf Holdings Inc., one of the world’s largest cannabis companies.

Cozen O’Connor will assist Massachusetts-based Curaleaf with banking issues facing the cannabis industry, according to a recent federal lobbying disclosure. The lobbying team will also represent Curaleaf in discussions surrounding the More Act, federal legislation that would remove marijuana from scheduling under the Controlled Substances Act.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]